HDAC5-mediated Exosomal Maspin and MiR-151a-3p As Biomarkers for Enhancing Radiation Treatment Sensitivity in Hepatocellular Carcinoma
Overview
Authors
Affiliations
Background: Tumor-derived exosomes are critical elements of the cell-cell communication response to various stimuli. This study aims to reveal that the histone deacetylase 5 (HDAC5) and p53 interaction upon radiation in hepatocellular carcinoma intricately regulates the secretion and composition of exosomes.
Methods: We observed that HDAC5 and p53 expression were significantly increased by 2 Gy and 4 Gy radiation exposure in HCC. Normal- and radiation-derived exosomes released by HepG2 were purified to investigate the exosomal components.
Results: We found that in the radiation-derived exosome, exosomal Maspin was notably increased. Maspin is known as an anti-angiogenic gene. The expression of Maspin was regulated at the cellular level by HDAC5, and it was elaborately regulated and released in the exosome. Radiation-derived exosome treatment caused significant inhibition of angiogenesis in HUVECs and mouse aortic tissues. Meanwhile, we confirmed that miR-151a-3p was significantly reduced in the radiation-derived exosome through exosomal miRNA sequencing, and three HCC-specific exosomal miRNAs were also decreased. In particular, miR-151a-3p induced an anti-apoptotic response by inhibiting p53, and it was shown to induce EMT and promote tumor growth by regulating p53-related tumor progression genes. In the HCC xenograft model, radiation-induced exosome injection significantly reduced angiogenesis and tumor size.
Conclusions: Our present findings demonstrated HDAC5 is a vital gene of the p53-mediated release of exosomes resulting in tumor suppression through anti-cancer exosomal components in response to radiation. Finally, we highlight the important role of exosomal Maspin and mi-151a-3p as a biomarker in enhancing radiation treatment sensitivity. Therapeutic potential of HDAC5 through p53-mediated exosome modulation in radiation treatment of hepatocellular carcinoma.
The paradoxical role of SERPINB5 in gastrointestinal cancers: oncogene or tumor suppressor?.
Zeng S, Zhang J, Jiang W, Zeng C Mol Biol Rep. 2025; 52(1):188.
PMID: 39899168 DOI: 10.1007/s11033-025-10293-w.
Wang B, Zhang N, Dai L, Zhang Y, Yin S, Yang X Discov Oncol. 2025; 16(1):63.
PMID: 39832042 PMC: 11747012. DOI: 10.1007/s12672-025-01805-y.
Liu Y, Jiang S, Zhang J, Zheng H, Zhang L, Zhao H Cell Biosci. 2024; 14(1):113.
PMID: 39227992 PMC: 11373138. DOI: 10.1186/s13578-024-01294-6.